L-Carnitine is a substance that occurs naturally
(Source: ASMBS, 2025) The researchers own conclusion is worth stating plainly: GLP-1 patients may need to adjust their expectations, adhere more closely to treatment, or opt for metabolic and bariatric surgery to achieve desired results. This isnt a case against GLP-1 therapy its a case for the structured, physician-supervised adherence support that determines whether patients get the results the clinical trials show are possible
Long-term data is still evolving, particularly as these medications are used more widely outside of diabetes care
One SCFA called butyrate boosts GLP-1
It is suggested that this encapsulation protects the glutathione molecule in the digestive tract and allows it to be better absorbed in the body
Jardiance family Disease area(s): Metabolic/cardiovascular Manufacturer(s): Boehringer Ingelheim/Eli Lilly and Company 2024 Sales (USD): $12.38 billion Why it sold so well: Co-developed by Boehringer Ingelheim and Eli Lilly, the Jardiance family experienced robust growth in 2024, driven by expanding clinical indications and strong global demand